The fact that TLX was identified as one of the significant mRNA responders to EGFR network perturbation when analyzed for a prognostic outcome prediction in glioblastoma multiforme,40 along with our results, highlight TLX as a crucial candidate for directed cancer therapy. Here, EGFR is linked to glioblastoma.